npj Precision Oncology (Sep 2021)

How I faced my prostate cancer: a molecular biologist’s perspective

  • Monica Zuradelli,
  • Massimo Lazzeri,
  • Egesta Lopci,
  • Paolo Andrea Zucali,
  • Luca Balzarini,
  • Giorgio Guazzoni,
  • Piergiuseppe Colombo,
  • Marta Scorsetti,
  • Ciro Franzese,
  • Rosanna Asselta,
  • Giulia Soldà,
  • Stefano Duga

DOI
https://doi.org/10.1038/s41698-021-00229-5
Journal volume & issue
Vol. 5, no. 1
pp. 1 – 4

Abstract

Read online

Hippocrates (Kos, c.460–c.370 BC) reminds us that “It is more important to know what sort of person has a disease than to know what sort of disease a person has”. This is still true today and reflects the emerging role of personalized medicine for patient-specific risk stratification and treatment programs. This report documents my personal experience as a patient with aggressive prostate cancer, who, as a scientist, had the privilege to access cutting-edge medical care and molecular profiling.